Sep 10, 2026 04:04PM
Aug 4, 2026 06:53AM
Aug 3, 2026 04:47PM
Jul 30, 2026 04:01PM
Jul 22, 2026 04:05PM
May 14, 2026 08:30AM
Mar 4, 2026 04:06PM Keros Therapeutics (KROS) Misses Q4 EPS by 16c
Nov 19, 2025 06:01AM
Nov 5, 2025 04:58PM
Oct 20, 2025 06:02AM
Oct 15, 2025 06:30AM
Sep 8, 2025 08:00AM
Aug 21, 2025 08:30AM
Aug 20, 2025 09:48AM Keros receives FDA orphan drug designation for KER-065 in DMD treatment
Aug 8, 2025 06:22AM
Aug 6, 2025 06:13PM
Aug 6, 2025 04:21PM
Jun 10, 2025 04:16AM
Jun 9, 2025 03:14PM
Jun 9, 2025 06:55AM
May 29, 2025 06:55AM Keros Therapeutics (KROS) Announces TROPOS Topline Data and Corporate Restructuring
May 27, 2025 01:45PM
May 21, 2025 08:06AM
May 8, 2025 02:10PM
May 8, 2025 06:43AM
May 6, 2025 04:20PM
Apr 10, 2025 02:08PM
Apr 10, 2025 06:19AM Keros Therapeutics (KROS) Announces Review of Strategic Alternatives
Apr 9, 2025 09:34AM
Mar 31, 2025 06:29AM
Mar 5, 2025 05:48AM
Feb 27, 2025 06:59AM
Feb 26, 2025 06:37PM
Jan 21, 2025 08:03AM
Jan 21, 2025 06:30AM Cantor Fitzgerald Downgrades Keros Therapeutics (KROS) to Neutral
Jan 17, 2025 10:40AM
Jan 16, 2025 08:24AM
Jan 16, 2025 06:59AM
Jan 15, 2025 02:57PM
Jan 15, 2025 06:30AM
Dec 23, 2024 03:11AM
Dec 16, 2024 07:36AM Keros Therapeutics (KROS) PT Lowered to $63 at Oppenheimer
Dec 13, 2024 07:17AM
Dec 13, 2024 05:21AM
Dec 12, 2024 09:45AM
Dec 12, 2024 09:05AM
Dec 12, 2024 06:16AM
Dec 5, 2024 07:07AM
Dec 3, 2024 10:52AM Keros Therapeutics (KROS) PT Raised to $77 at BofA Securities
Dec 3, 2024 07:00AM

448,109 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All